
StudyFinder
A Study to Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASH

OPEN TO ACCRUAL
drug: Vk2809
Diseases of Digestive System (520-579)
Hurst, Caitlin - hurstc3@vcu.edu
Sanyal, Arun, J
II
HM20018948
NCT04173065
See this study on ClinicalTrials.gov